Read our monthly Blog, Case Studies and White Papers to learn more about how we optimize market access for Channel/Trade, Payer and Patient Services
Case Study:
Developing a PSP Strategy that Identifies and Addresses Unique Therapeutic Challenges

By Mike Scott, Partner & David Frey, Senior Consultant
1.18.2021


When healthcare providers are faced with the need to initiate or switch therapy for patients with chronic medical conditions, a key goal is to optimize clinical response and tolerability. When the efficacy profiles of treatment options are comparable, most healthcare providers and patients consider the ease-of-administration and formulation as key factors, along with ease-of-access, insurance coverage and dosing schedule. However, the more sophisticated the therapy, the more patients want and need to feel supported by their provider, and often just as importantly, by the product’s Patient Support Program (PSP). This increased need for patient support can elevate a PSP up the list of deciding factors. For infused and injectable therapies, if a comprehensive PSP with adequate provider support isn’t available, prescribing practitioners and their patients may select an alternative treatment option that does offer strong support for the practice, the patient, and (if appropriate) the patient’s caregiver.